GILEAD SCIENCES INC (GILD:NASDAQ)
$145.68 -3.18 (-2.1362%)
Analysed GILEAD SCIENCES INC (GILD:NASDAQ) News Sources
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
24-08-2026
yahoo.com
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
23-08-2026
yahoo.com
Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
23-08-2026
yahoo.com
European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status
24-08-2026
yahoo.com
GILD Stock Garners Retail Attention On Trodelvy EU Approval Ahead Of August 27 HIV FDA Verdict
24-08-2026
stocktwits.com
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
26-08-2026
fool.com
Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
26-08-2026
yahoo.com
Gilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?
27-08-2026
yahoo.com
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
27-08-2026
yahoo.com
Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run
27-08-2026
yahoo.com
What is the current price of GILEAD SCIENCES INC (GILD:NASDAQ)?
The current price of GILEAD SCIENCES INC (GILD:NASDAQ) is $145.68.
GILEAD SCIENCES INC (GILD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is $-3.18.
GILEAD SCIENCES INC (GILD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is -2.1362%.
What is the most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent sentiment for GILEAD SCIENCES INC (GILD:NASDAQ) is .
SEC-8K** Filing Available For GILEAD SCIENCES INC (GILD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.